Centre for Immune Regulation, Institute of Immunology, University of Oslo, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Amino Acids. 2010 Nov;39(5):1183-91. doi: 10.1007/s00726-010-0554-y. Epub 2010 Mar 19.
Transglutaminase 2 (TG2) is well characterized as the main autoantigen of celiac disease. The ability of TG2 to deamidate and crosslink gluten peptides is essential for the gluten-dependent production of TG2 specific autoantibodies. In patients with primarily extraintestinal manifestation of gluten sensitivity the repertoire of autoantibodies may be different. In dermatitis herpetiformis (DH), TG3 appears to be the target autoantigen whereas in gluten ataxia (GA) autoantibodies reactive with TG6 are present. A functional role for TG3 and TG6 in these diseases has yet to be described. It is also not known whether these enzymes can use gluten peptides implicated in the pathology as substrates. We here report that similar to TG2, TG3 and TG6 can specifically deamidate gluten T cell epitopes. However, the fine specificities of the enzymes were found to differ. TG2 can form covalent complexes with gluten by iso-peptide and thioester bonds. We found that both TG3 and TG6 were able to complex with gluten peptides through thioester linkage although less efficiently than TG2, whereas TG6 but not TG3 was able to form iso-peptide linked complexes. Our findings lend credence to the notion that TG3 and TG6 are involved in the gluten-induced autoimmune responses of DH and GA.
转谷氨酰胺酶 2(TG2)是明确的乳糜泻的主要自身抗原。TG2 脱酰胺和交联麸质肽的能力对于麸质依赖性 TG2 特异性自身抗体的产生至关重要。在主要表现为肠外麸质敏感性的患者中,自身抗体的 repertoire 可能不同。在疱疹样皮炎(DH)中,TG3 似乎是靶自身抗原,而在麸质共济失调(GA)中存在与 TG6 反应的自身抗体。TG3 和 TG6 在这些疾病中的功能作用尚未被描述。也不知道这些酶是否可以将涉及病理学的麸质肽作为底物。我们在这里报告,类似于 TG2,TG3 和 TG6 可以特异性地脱酰胺麸质 T 细胞表位。然而,发现这些酶的精细特异性不同。TG2 可以通过异肽和硫酯键与麸质形成共价复合物。我们发现,TG3 和 TG6 都能够通过硫酯键与麸质肽形成复合物,尽管效率低于 TG2,但 TG6 而不是 TG3 能够形成异肽连接的复合物。我们的发现证实了 TG3 和 TG6 参与 DH 和 GA 中麸质诱导的自身免疫反应的观点。
Nutrients. 2020-9-21
Neurology. 2013-4-10
Recent Adv Inflamm Allergy Drug Discov. 2025
World J Clin Cases. 2024-4-26
Brain Commun. 2024-3-7
Pathophysiology. 2021-12-18